Forus
About Forus
Forus is a Digital Health startup based in New York, United States that has raised $130M in venture capital across 2 funding rounds since 2023. The company reached Series B stage in 2024 with a $30M round led by General Catalyst. Forus's investor base includes 4 institutional funds, with Accel leading the most recent equity round.
Forus (formerly Tandem) is an AI-powered platform that automates prescription fulfillment, handling prior authorizations, appeal letters, pharmacy routing, and medication access for healthcare providers — at no cost to patients or providers. The platform connects doctors, pharmacies, payers, and biopharma to improve medication access across all 50 US states. Thousands of medical practices and health systems use Forus, with five of the top ten pharmaceutical companies collaborating with the platform.
Forus Funding Rounds Timeline
2 rounds · $130M raised · since 2023
| Round | Date | Amount | Valuation | Lead investor | Co-investors |
|---|---|---|---|---|---|
| Series A | 2024 | $30M | — | General Catalyst | Thrive Capital |
| Series B | January 2026 | $100M | $1B | Accel | Thrive Capital, Bain Capital Ventures |
Investors in Forus
4 institutional investors across 2 rounds
Lead investors
Co-investors
Recent news about Forus
- startup_fundraisingBuilding the Foundation for Modern Medicine: Our Series B Investment in Forus
Questions about Forus
How much has Forus raised?
Forus has raised $130M across 2 funding rounds since 2023.
Who are the investors of Forus?
Forus's investors include Accel, General Catalyst, Thrive Capital, Bain Capital Ventures.
When was Forus's last funding round?
Forus's most recent round was a $30M Series A in 2024, led by General Catalyst.
What is Forus's valuation?
Forus reached a $1B valuation (unicorn status) with its Series A round in 2024.
Where is Forus headquartered?
Forus is headquartered in New York, United States, and was founded in 2023 by Sahir Jaggi.